Radiation Sickness Latest Advances

Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research.

Journal: Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc

Published: April 14, 2026

Intelligent model for stratification of acute radiation syndrome severity in humans.

Journal: International journal of radiation biology

Published: March 05, 2026

Cytokine use in the Hematopoietic Subsyndrome of Acute Radiation Syndrome (H-ARS): Implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Journal: Journal of radiological protection : official journal of the Society for Radiological Protection

Published: February 12, 2026

Bone Marrow Colony Stimulating Factors (CSF) and Stem Cell Therapy as Medical Countermeasures (MCM) for Treatment of Hematopoietic-Acute Radiation Syndrome: A Systematic Review.

Journal: Disaster medicine and public health preparedness

Published: February 09, 2026

A Defined Patho-Mechanism for Acute Radiation Syndrome Death and a Three-Drug Regimen to Prevent It.

Journal: International journal of molecular sciences

Published: February 07, 2026

Cytokine use in the hematopoietic subsyndrome of acute radiation syndrome (H-ARS): implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Journal: Journal of radiological protection : official journal of the Society for Radiological Protection

Published: September 18, 2025

Impact of Dose Administration Schedule and Orthovoltage X-ray Beam Quality on Survival and Dose Response Relationships in C57BL/6J Mouse Models of Acute Radiation Syndrome.

Journal: Radiation research

Published: September 18, 2025

Development of an Extended-release Formulation of Radioprotectin-1 for Mitigation of Gastrointestinal Acute Radiation Syndrome.

Journal: Radiation research

Published: September 03, 2025

Development of Nanocarrier-Based Oral Pegfilgrastim Formulations for Mitigating Hematopoietic Acute Radiation Syndrome.

Journal: Advanced functional materials

Published: August 15, 2025

Matching biodosimetry to likely types of exposure and needs for triage for medical management of radiation syndrome following a nuclear event.

Journal: International journal of radiation biology

Published: August 04, 2025

New MRI findings of late delayed radiation injuries in long-term survivors after radiotherapy: punctate enhancing dot-, oval-, or rod-like lesions.

Journal: Neuroradiology

Published: August 03, 2025

Ghrelin mitigates partial body irradiation-induced gastrointestinal acute radiation syndrome by promoting intestinal stem cell regeneration.

Journal: Molecular medicine (Cambridge, Mass.)

Published: July 28, 2025

Radiation Sickness Latest Advances

Find the Latest Research About Radiation Sickness

Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research.

Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research.

Intelligent model for stratification of acute radiation syndrome severity in humans.

Intelligent model for stratification of acute radiation syndrome severity in humans.

Cytokine use in the Hematopoietic Subsyndrome of Acute Radiation Syndrome (H-ARS): Implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Cytokine use in the Hematopoietic Subsyndrome of Acute Radiation Syndrome (H-ARS): Implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Bone Marrow Colony Stimulating Factors (CSF) and Stem Cell Therapy as Medical Countermeasures (MCM) for Treatment of Hematopoietic-Acute Radiation Syndrome: A Systematic Review.

Bone Marrow Colony Stimulating Factors (CSF) and Stem Cell Therapy as Medical Countermeasures (MCM) for Treatment of Hematopoietic-Acute Radiation Syndrome: A Systematic Review.

A Defined Patho-Mechanism for Acute Radiation Syndrome Death and a Three-Drug Regimen to Prevent It.

A Defined Patho-Mechanism for Acute Radiation Syndrome Death and a Three-Drug Regimen to Prevent It.

Cytokine use in the hematopoietic subsyndrome of acute radiation syndrome (H-ARS): implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Cytokine use in the hematopoietic subsyndrome of acute radiation syndrome (H-ARS): implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Impact of Dose Administration Schedule and Orthovoltage X-ray Beam Quality on Survival and Dose Response Relationships in C57BL/6J Mouse Models of Acute Radiation Syndrome.

Impact of Dose Administration Schedule and Orthovoltage X-ray Beam Quality on Survival and Dose Response Relationships in C57BL/6J Mouse Models of Acute Radiation Syndrome.

Development of an Extended-release Formulation of Radioprotectin-1 for Mitigation of Gastrointestinal Acute Radiation Syndrome.

Development of an Extended-release Formulation of Radioprotectin-1 for Mitigation of Gastrointestinal Acute Radiation Syndrome.

Development of Nanocarrier-Based Oral Pegfilgrastim Formulations for Mitigating Hematopoietic Acute Radiation Syndrome.

Development of Nanocarrier-Based Oral Pegfilgrastim Formulations for Mitigating Hematopoietic Acute Radiation Syndrome.

Matching biodosimetry to likely types of exposure and needs for triage for medical management of radiation syndrome following a nuclear event.

Matching biodosimetry to likely types of exposure and needs for triage for medical management of radiation syndrome following a nuclear event.

New MRI findings of late delayed radiation injuries in long-term survivors after radiotherapy: punctate enhancing dot-, oval-, or rod-like lesions.

New MRI findings of late delayed radiation injuries in long-term survivors after radiotherapy: punctate enhancing dot-, oval-, or rod-like lesions.

Ghrelin mitigates partial body irradiation-induced gastrointestinal acute radiation syndrome by promoting intestinal stem cell regeneration.

Ghrelin mitigates partial body irradiation-induced gastrointestinal acute radiation syndrome by promoting intestinal stem cell regeneration.